Morgan Stanley’s Arcellx ACLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-925,813
| Closed | -$106M | – | 8403 |
|
|
2026
Q1 | $106M | Buy |
925,813
+407,409
| +79% | +$36M | 0.01% | 1392 |
|
|
2025
Q4 | $33.8M | Buy |
518,404
+85,522
| +20% | +$6.82M | ﹤0.01% | 2462 |
|
|
2025
Q3 | $35.5M | Sell |
432,882
-84,631
| -16% | -$6.09M | ﹤0.01% | 2329 |
|
|
2025
Q2 | $34.1M | Buy |
517,513
+55,180
| +12% | +$3.44M | ﹤0.01% | 2276 |
|
|
2025
Q1 | $30.3M | Sell |
462,333
-155,784
| -25% | -$10.6M | ﹤0.01% | 2278 |
|
|
2024
Q4 | $47.4M | Sell |
618,117
-139,035
| -18% | -$12M | ﹤0.01% | 1882 |
|
|
2024
Q3 | $63.2M | Buy |
757,152
+212,075
| +39% | +$14.1M | ﹤0.01% | 1618 |
|
|
2024
Q2 | $30.1M | Sell |
545,077
-151,685
| -22% | -$8.25M | ﹤0.01% | 2226 |
|
|
2024
Q1 | $48.5M | Buy |
696,762
+23,477
| +3% | +$1.49M | ﹤0.01% | 1785 |
|
|
2023
Q4 | $37.4M | Buy |
673,285
+568,027
| +540% | +$25.6M | ﹤0.01% | 2022 |
|
|
2023
Q3 | $3.78M | Sell |
105,258
-173,853
| -62% | -$5.99M | ﹤0.01% | 3941 |
|
|
2023
Q2 | $8.83M | Buy |
279,111
+170,713
| +157% | +$6.53M | ﹤0.01% | 3287 |
|
|
2023
Q1 | $3.34M | Sell |
108,398
-15,097
| -12% | -$458K | ﹤0.01% | 4101 |
|
|
2022
Q4 | $3.83M | Buy |
123,495
+26,790
| +28% | +$614K | ﹤0.01% | 3982 |
|
|
2022
Q3 | $1.81M | Buy |
96,705
+19,562
| +25% | +$374K | ﹤0.01% | 4509 |
|
|
2022
Q2 | $1.4M | Buy |
77,143
+76,105
| +7,332% | +$982K | ﹤0.01% | 4793 |
|
|
2022
Q1 | $14K | Buy |
+1,038
| New | +$17.4K | ﹤0.01% | 7277 |
|
Other funds holding ACLX
Morgan Stanley's ACLX Position: Q2 2026 in Review
Morgan Stanley sold out of Arcellx (ACLX) in Q2 2026, closing a stake of 925,813 shares — an estimated $106M sold.
Morgan Stanley first reported a position in ACLX in Q1 2022 and held it in 17 quarters. The position peaked at $106M in Q1 2026. 2 funds tracked by Wall St. Rank hold ACLX as of Q2 2026.
- Morgan Stanley reported no remaining Arcellx position as of Q2 2026 after selling out during the quarter.
- Morgan Stanley sold 925,813 Arcellx shares in Q2 2026, an estimated $106M.
- Morgan Stanley first reported a position in Arcellx in Q1 2022 and held it in 17 quarters.
- Morgan Stanley's Arcellx position peaked at $106M in Q1 2026.
- 2 funds tracked by Wall St. Rank held Arcellx as of Q2 2026.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.